LWAM
ABBV icon

Legacy Wealth Asset Management’s AbbVie ABBV Stock Holding History

Legacy Wealth Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,929
Closed -$1.23M – 293
2021
Q2 		$1.23M Buy
10,929
+116
+1% +$13.1K 0.55% 35
2021
Q1 		$1.17M Buy
10,813
+241
+2% +$25.8K 0.54% 36
2020
Q4 		$1.13M Buy
+10,572
New +$1.02M 0.57% 35

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Legacy Wealth Asset Management's ABBV Position: Q3 2021 in Review

Legacy Wealth Asset Management sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 10,929 shares — an estimated $1.23M sold.

Legacy Wealth Asset Management first reported a position in ABBV in Q4 2020 and held it in 3 quarters. The position peaked at $1.23M in Q2 2021. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Legacy Wealth Asset Management reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 10,929 AbbVie shares in Q3 2021, an estimated $1.23M.
  • Legacy Wealth Asset Management first reported a position in AbbVie in Q4 2020 and held it in 3 quarters.
  • Legacy Wealth Asset Management's AbbVie position peaked at $1.23M in Q2 2021.
  • 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Legacy Wealth Asset Management's 13F filing for Q3 2021, filed 19 Oct 2021.